2940-nm erbium:YAG laser versus 980-nm diode laser in the treatment of multiple seborrheic keratoses: A prospective comparative randomized study

J Cosmet Dermatol. 2022 Nov;21(11):5628-5635. doi: 10.1111/jocd.15096. Epub 2022 Jun 4.

Abstract

Background: Seborrheic keratoses (SKs) are the most common benign epithelial tumors encountered in clinical practice. Complications associated with traditional treatments of SKs urge the scientists to seek alternative treatment modalities. Objective To compare the efficacy and safety of 2940-nm erbium-doped yttrium aluminum garnet (Er:YAG) laser versus 980-nm diode laser both clinically and dermoscopically for the treatment of seborrheic keratosis.

Methods: Thirty subjects with multiple SKs were randomized to receive two sessions of either Er:YAG laser (n = 15) or diode laser (n = 15) and were followed up for 2 weeks after each session, and at 3 and 6 months after the second session.

Results: Both lasers exhibited significant clearance of SKs with no significant difference in clinical and dermoscopic improvement between the two systems. However, Er:YAG laser showed shorter total downtime but more serious erythema, while scarring and hyperpigmentation were observed in diode laser group. No recurrence was detected in both groups at 6 months follow-up.

Conclusion: Er:YAG and diode lasers both are effective, non-invasive and well-tolerated techniques in treatment of SKs.

Keywords: Er:YAG laser; dermoscopy; diode laser; seborrheic dermatosis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Erbium
  • Humans
  • Keratosis, Seborrheic* / surgery
  • Laser Therapy*
  • Lasers, Semiconductor / adverse effects
  • Lasers, Solid-State* / adverse effects
  • Prospective Studies
  • Treatment Outcome

Substances

  • Erbium